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Abstract
The natural polymers chitosan and alginate represent an attractive material choice for
biodegradable inplants. These were used as coating materials to make positively and negatively
charged PLGA nanoparticles, respectively. After blending at total solids concentration >10% wt/
vol, these oppositely charged nanoparticles yielded a cohesive colloidal gel. Electrostatic forces
between oppositely charged nanoparticles produced a stable 3-D porous network that may be
extruded or molded to the desired shape. This high concentration colloidal system demonstrated
shear-thinning behavior due to the disruption of interparticle interactions. Once the external force
was removed, the cohesive property of the colloidal gel was recovered. Scanning electron
micrographs of dried colloidal networks revealed an organized, 3-D microporous structure.
Rheological studies were employed to probe the differences in plasticity and shear sensitivity of
colloidal gels. Viability tests of hUCMSCs seeded on the colloidal gels also demonstrated the
negligible cytotoxicity of the materials. All the results indicated the potential application of the
biodegradable colloidal gels as an injectable scaffold in tissue engineering and drug release.
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1. Introduction
Injectable scaffolds have received attention due to their potential for avoiding the invasive
surgery typically required for tissue implantation.1 From a clinical perspective, the use of
injectable materials is an attractive alternative to surgery as it reduces the risk of infection,
scar formation, patient discomfort and the cost of treatment.2 Injectable scaffolds may be
applied to fill tissue defects of irregular size and shape. Next generation injectable scaffolds
should exhibit modest viscosity upon administration to ensure retention at the defect site,
and may benefit from on increase in viscosity upon placement. Recently, many scaffolds
that stiffen or solidify in vivo have been applied as injectable tissue scaffolds.3–4 Usually,
injectable scaffolds are polymerized or chemically crosslinked to stiffen the material. In this
way, scaffolds may form via an in situ reaction induced by the presence of water, heat, light
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or other stimuli. During the process of solidification, however, toxic chemical agents are
sometimes employed, which may adversely affect the scaffolds, destabilize encapsulated
biomolecules, or pose toxicity concerns. So, new materials that may stiffen through
interactions such as electrostatic forces, van der Waals attraction and steric hindrance are
desirable in the applications.
Naturally occurring polymers exhibit multiple desirable properties as scaffolds in tissue
engineering.5 Depending on the material and the source, certain natural polymers have been
identified as biodegradable, non-antigenic, non-toxic and biofunctional.6–9 The hydrophilic
properties of many of these molecules and ample functional groups for further modification
also make natural polymers excellent candidates for biomedical appications.10–11 Chitosan
and alginate are two major naturally occurring polysaccharides which have been widely
used as drug delivery systems and tissue scaffolds.12–15 Chitosan is a natural cationic
polymer obtained by deacetylating chitin comprising copolymers of β (1 → 4)-glucosamine
and N-acetyl-D-glucosamine. When chitosan is dissolved in a dilute acid solution, the amino
groups become protonated and introduce positive charge to the polymer.16 Alginate is a
natural anionic polymer derived from brown sea algae. Alginate has carboxyl groups which
may introduce negative charge to the polymer at appropriate pH.17 These two natural
polyelectrolyte can facilitate the formation of oppositely charged biomedical materials.
Colloidal gels with three-dimensional (3-D) microperiodic structures comprised of
biodegradable materials were manufactured to overcome some of these limitations.18–19
These colloidal systems were composed of oppositely-charged nanoparticles at high
concentration and stiffen through interparticle interactions such as electrostatic forces and
van der Waals attraction.20 Colloidal gels exhibiting pseudoplastic behavior resulting from
interparticle interactions can facilitate the fabrication of shape-specific macroscale materials
with 3-D architectures.21–22 Recent research in materials science has aimed to leverage
these phenomena to achieve unique bulk material properties for many different applications.
23–28 The application of moldable colloidal gels towards generating tissues has also been
proposed.29–30
Here, natural polymers were integrated into biodegradable colloidal gels and examined for
their potential as injectable tissue scaffolds. Poly (D, L-lactic-co-glycolic acid) (PLGA) is a
biocompatible and biodegradable polymer, which has been approved in pharmaceutical
products and used in tissue engineering scaffolds.31–34 Chitosan and alginate were
employed as surface modifiers to make oppositely-charged PLGA nanoparticles. Cohesive
colloidal gels were created by simply mixing the oppositely-charged PLGA nanoparticles at
different ratios. These materials exhibited desirable rheological properties for facile injection
as tissue scaffolds. Colloidal gels were also highly compatible with human umbilical cord
mesenchymal stem cells (hUCMSCs), which further supported possible translation of these
materials.
2. Materials and methods
2.1. Materials
All materials were purchased from Fisher Scientific Inc. unless otherwise stated. PLGA
(75:25) (7525 DLG 2.5E) was purchased from Lakeshore Biomaterials. Chitosan (448869,
DD (degree of deacetylation) was 75–85%, Mn was 612 kDa ) was obtained from Sigma-
Aldrich Co., Alginate sodium (Mv= 1.6×105, viscosity was 39 MPas in 1.0% solution at 20
°C) was purchased from FMC BioPolymer.
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2.2. Preparation of charged PLGA nanoparticles
Oppositely-charged PLGA nanoparticles were prepared by a solvent diffusion method. 100
mg of PLGA was dissolved in 10 mL acetone and then the solution was added into chitosan
(dissolved in 0.2% wt/vol acetic acid solution) or alginate (dissolved in deionized water)
surfactant solution with different concentration (0.1%, 0.2%, 0.5% and 1.0%) through a
syringe pump at constant rate (20 mL/h, 40 mL/h and 60 mL/h) under stirring at 200 rpm
overnight to evaporate acetone. Nanoparticles were collected by centrifugation (Beckman
Co., Avanti 30) (14,000 rpm, 15 min). The nanoparticles were resuspended using deionized
water and centrifuged three times to remove excess chitosan or alginate. A fine powder of
charged nanoparticles was obtained by lyophilization for ~2 days.
2.3. Preparation of colloidal gels
Lyophilized nanoparticles (PLGA-Chitosan or PLGA-Alginate) were dispersed in deionized
water at the reported concentrations. These dispersions were mixed in different proportions
to obtain the different weight ratios studied. Homogeneous colloid mixtures were prepared
in a bath sonicator for 3 minutes and stored at 4 °C for 2 h to allow particles to be
structurally organized before use. Several colloidal gels, with different mass ratios of
PLGA-chitosan nanoparticles to PLGA-alginate nanoparticles, were designated as C100,
CA37, CA55, CA73 and A100 (C: PLGA-chitosan nanoparticles; A: PLGA-alginate
nanoparticles; the weight ratios of PLGA-chitosn nanoparticles to PLGA-alginate
nanoparticles were 100:0, 30:70, 50:50, 70:30 and 0:100, respectively).
2.4. Characterization of nanoparticles and colloidal gels
The sizes and zeta potentials of the different PLGA nanoparticles were determined using a
ZetaPALS dynamic light scattering system (Brookhaven, ZetaPALS). All samples were
analyzed in triplicate. Scanning electron microscopy (SEM) was performed using a Jeol
JSM-6380 field emission scanning electron microscope at an accelerating voltage of 10kV.
2.5. Rheological experiments
Rheological experiments were performed using a controlled stress rheometer (AR2000, TA
Instrument Ltd.). 2° cone steel plates (20 mm diameter) were used and the 500 μm gap was
filled with tested colloidal gel. A solvent trap was used to prevent evaporation of water. The
viscoelastic properties of the sample were determined at 20 °C by forward-and-backward
stress sweep experiments. The viscosity (η) was monitored while the stress was increased
and then decreased (frequency = 1 Hz) in triplicate with 10 minutes between cycles. The gel
recoverability was assessed using defined time breaks between cycles. All samples were
analyzed in triplicate.
2.6. Cytotoxicity
hUCMSCs were harvested and cultured until passage 2 as previously described35 for cell
seeding in culture medium, which included low glucose Dulbecco’s Modified Eagle’s
Medium, 10% FBS, and penicillin/streptomycin (PS). Then, hUCMSCs were seeded at a
density of 1×104 cells per cm2. Cells were grown to near confluence in the individual wells
of a 12-well tissue culture-treated plate and then exposed to 100, 200, and 300 μl of colloidal
gel. The working concentrations of the nanoparticles used were as follows: PLGA 2 mg/ml;
chitosan 30 mg/ml; and alginate 30 mg/ml. Cells were cultured on the colloidal gels for 48
hours and 2 weeks, the media being carefully changed every 2–3 days without disturbing the
settled gels at the bottom. Subsequently, the cells were stained with LIVE/DEAD reagent
(dye concentration 2 mM calcein AM, 4 mM ethidium homodimer-1; Molecular Probes) and
incubated for 45 mins, before being subjected to fluorescence microscopy (Nikon TS 100
with Epifluoresence Attachment).
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3. Results and discussion
3.1. PLGA nanoparticles were coated with natural biopolymers
The entire process for the fabrication of PLGA nanoparticle colloidal gels is illustrated in
Figure 1. In the first step, PLGA nanoparticles were prepared by a solvent diffusion method.
The precipitation of PLGA nanoparticles occurred in the respective polyelectrolyte solution,
chitosan or alginate, resulting in a coating of either polymer on the nanoparticle surface.
Chitosan introduced positive charge and alginate introduced negative charge on the surface
of PLGA nanoparticles. The particle sizes (Figure 2) and zeta potentials (Figure 3) of each
particle type depended on the synthesis conditions. The injection rate of the dissolved PLGA
and the concentration of the biopolymer solution were two key factors influencing the sizes
and zeta potentials of the nanoparticles.
During the fabrication process, PLGA precipitated to form nanoparticles as the organic
solvent mixed with water. The faster injection rate resulted in a higher local concentration of
PLGA at the needle tip, therefore, larger nanoparticles were produced (Figure 2). In
addition, the concentration of biopolymer solution (chitosan or alginate) determined the
magnitude of the nanoparticle surface charge. Increasing the concentration of biopolymer
solution induced a higher charge on the nanoparticles, since presumably more
polyelectrolyte was associated with the nanoparticle surface (Figure 3). In order to balance
the particle sizes and zeta potentials of the two oppositely charged particles, 248.5±11.9 nm
PLGA-chitosan nanoparticles with a zeta potential of +18.8±3.2 mV and 181.6±3.3 nm
PLGA-alginate nanoparticles with a zeta potential of −23.4±1.2 mV were prepared for
colloidal gel experiments by injecting PLGA solution into 0.2% polyelectrolyte solution at a
constant rate of 40 mL/h. The optimized nanoparticles were collected and used to prepare
colloidal gels.
3.2. PLGA colloidal gels exhibited microporous structures and shape retention
For initial studies, cationic or anionic nanoparticles were suspended in deionized water at
20% (w/w) at room temperature. SEM pictures of dried colloidal networks revealed little
difference in the structure of dried gels containing different mass ratios of oppositely-
charged nanoparticles (Figure 4). After drying, all mass ratios (3:7, 1:1, and 7:3; PLGA-
chitosan: PLGA-alginate) exhibited a loosely organized, microporous structure. The
oppositely-charged nanoparticles were linked together to form micrometer-scale, ring-like
structures with microchannels, which interconnected to form the bulk porous structure
observed. Domains of more tightly packed nanoparticle agglomerates were evident,
suggesting that the cohesive nature of colloidal gels results from the equilibrium of
interparticle attractions (tight agglomerates) and repulsions (pores).
Colloidal gels composed of oppositely-charged nanoparticles at high concentration exhibit
unique pseudoplastic properties facilitating the fabrication of shape-specific microscale
materials. In this project, the pseudoplastic behavior of colloidal gels was leveraged to
construct tissue engineering scaffolds of the desired shape (Figure 5). The colloidal gels kept
their shape for several hours unless changed by an external force. The colloidal gels with
different compositions showed slight differences in moldability due to the different ratios of
oppositely charged PLGA nanoparticles. Colloidal gel composed of a more equal overall
charge balance (CA55 with 1:1 mass ratio, Figure 5B) exhibited less fluidity and better
shape stability. Pure nanoparticles at the same concentration showed no moldability (pure
PLGA-chitosan nanoparticles, Figure 5D). Results confirmed that the overall charge ratio
determined the bulk and microscopic structures and properties of the colloidal system.36 In
this research, the small size and high charge of the PLGA nanoparticles were leveraged to
form stable colloidal gels.
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3.3. PLGA colloidal gels were shear thinning with recoverable stiffness
Rheological studies were employed to probe the differences in viscoelasticity of colloidal
gels. Equal mass ratios of nanoparticles yielded the highest viscosity gel and improved
reversibility compared to other ratios (Figure 6). As expected, colloidal gels containing more
positively-charged particles (CA73, 7:3 mass ratio, 20% concentration) exhibited higher
viscosity, while colloidal gels composed of excess negatively-charged particles (CA37, 3:7
mass ratio, 20% concentration) exhibited more fluidity. The larger zeta potential of
negatively charged nanoparticles resulted in a more equal overall charge balance when
positively charged particles were in excess, thus, providing a probable explaination for the
stronger cohesion and enhanced reversibility observed in the 7:3 mass ratio compared to the
3:7 mass ratio. Pure nanoparticle suspensions exhibited minimal shear-thinning behavior
(C100 and A100).
The viscosity of colloidal gel was enhanced and shear-thinning more pronounced a s t h e
concentration of nanoparticles increased (Figure 7). Consecutive acceleration/deceleration
cycles of the shear force applied to CA55 colloidal gels (20% concentration) revealed that
these materials did not rapidly recover (Figure 8). Delaying shear cycles for more time may
enhance the recovery of gel viscosity. All the results suggested that the colloidal gels were
desirable for injectable applications.
For colloidal gels, the strength of the cohesion depends upon the interparticle interactions
such as electrostatic forces and van der Waals attractions.20 These interparticle interactions
were controlled by the composition of the colloidal gels, such as concentration and ratio of
the two oppositely-charged particles. PLGA-chitosan and PLGA-alginate nanoparticles self-
assembled through interparticle interactions resulting in a stable 3-D porous network. Under
static conditions, the viscosity and structure of colloidal assemblies leading to a stable
structure exhibiting high viscosity at equilibrium (Figure 5, A–C). If the particle-particle
equilibrium is disrupted, e.g. by external force applied to disrupt the interparticle
interactions, the colloidal system will demonstrate shear-thinning behavior. Once the
external force is removed, the strong cohesive property of the colloidal gel is recovered and
the 3D porous structure is reconstructed. This reversibility makes the gel an excellent
material for applications in molding, extrusion, or injection of tissue scaffolds and drug
delivery systems.
3.4. PLGA colloidal gels had negligible cytotoxicity to hUCMSCs
Stem cell based tissue engineering has the potential to revolutionize biomedicine with the
ability to repair or regenerate the damaged or diseased tissue.37–38 hUCMSCs are
multipotent, able to differentiate into adipocytes, osteoblasts, chondrocytes, neurons, and
other cells.39–42 Comparing to other stem cells, hUCMSCs are advantageous because
umbilical cords can be collected at a low cost and represent an inexhaustible stem cell
source. hUCMSCs can be harvested from discarded umbilical cords, expanded in culture,
induced to differentiate and combined with a scaffold to repair tissue defects.43–44 However,
pre-formed carriers for cell delivery have drawbacks including the difficulties in seeding the
cells on the scaffold, biocompatibility between the cells and the scaffolds, and placement in
minimally invasive surgeries.45 In this research, biodegradable PLGA colloidal gels were
used to overcome these difficulties.
hUCMSCs were harvested and cultured on CA55 and CA37 colloidal gels for up to two
weeks, following which, viability assays were conducted. The Live/Dead Cytotoxicity
Assay Kit from Molecular Probes was employed, which uses two probes, namely Calcein
AM and Ethidium Bromide homodimer, to identify two critical matrices of cell viability: (a)
protease activity and (b) membrane integrity. The membrane-permeable dye Calcein/AM
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(Ex495nm/Em515nm) was hydrolyzed by cellular proteases, ubiquitous in living cells, to
yield a green fluorescent product; on the contrary, ethidium homodimer (Ex495/Em635nm)
only entered the cell membranes of dead or dying cells to bind the DNA, undergoing a
manifold enhancement in red fluorescence (Figure 9). Very little cell death was observed in
cells treated with PLGA nanoparticles for 48 hours and for 2 weeks. On the other hand,
when 70 % ethanol was used as a negative control, appreciably higher numbers of dead cells
were observed. The live/dead experiments qualitatively demonstrated that PLGA colloidal
gels possessed little cytotoxicity towards hUCMSCs, which suggested that the material may
be used as a scaffold for seeding stem cells.
4. Conclusions
In this paper, a new colloidal gel made by oppositely-charged PLGA nanoparticles coated
with naturally occurring polyelectrolytes was reported. The cohesive strength of the
colloidal gels resulted from the interparticle interactions between the oppositely-charged
nanoparticles. The shear sensitivity to external force and recoverable pseudoplastic property
make it an excellent injectable biomaterial. Cytotoxicity tests of the colloidal gels also
demonstrated negligible toxicity to hUCMSCs. Thus, injectable PLGA colloidal gels
represent a promising new material for tissue engineering. In further research, integration of
controlled release of active ingredients (e.g. growth factors) will allow for advanced
combination strategies for tissue engineering coupled with drug release.
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Schematic presentation of the process for fabrication of oppositely charged PLGA
nanoparticles and formation of colloidal gel.
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Sizes of PLGA nanoparticles made in chitosan or alginate solution with different
concentrations (0.1%, 0.2%, 0.5% and 1.0%) at different injection rates ( 20 mL/h, 40 mL/h
and 60 mL/h) by syringe pump.
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Zeta potentials of PLGA nanoparticles made in chitosan or alginate solution with different
concentration (0.1%, 0.2%, 0.5% and 1.0%) at different injection rates ( 20 mL/h, 40 mL/h
and 60 mL/h) by syringe pump (chitosan embued positive charge and alginate embued
negative charge).
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SEM images of colloidal gels (A) CA37, (B) CA55 and (C) CA73 (scale bar = 1µm).
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Shaped tissue scaffolds made by colloidal gels (A) CA37, (B) CA55, (C) CA73 and (D) pure
PLGA-chitosan nanoparticles.
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Viscosity and shear-thinning behavior of colloidal gels (20% concentration) mixed at
different ratios for accelerating (solid symbols) and decelerating (open symbols) shear force.
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Viscosity and shear-thinning behavior of CA55 colloidal gel at different concentrations for
accelerating (solid symbols) and decelerating (open symbols) shear force when no recovery
time was allowed between shear cycles.
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Viscosity and shear-thinning behavior of CA55 colloidal gel (20% concentration) for
repeated accelerating (solid symbols) and decelerating (open symbols) shear force when no
recovery time was allowed between shear cycles.
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Human umbilical cord matrix stem cells cultured on colloidal gels CA 55 (B) and CA37 (C)
demonstrated high viability (green) and minimal cell death (red) comparing to reference (A,
treated without colloidal gels).
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